Medical Device Investing Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
Psychedelics Investing DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Champignon Brands Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Psychedelics Investing Final Deadline to Actively Participate in Champignon Brands Inc. Class Action - Bronstein, Gewirtz & Grossman, LLC
Medical Device Investing Johnson & Johnson Releases 2020 Health for Humanity Report Highlighting Performance and Progress on Environmental, Social and Governance Priorities
BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET
Pharmaceutical Investing Merck Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19
Awakn Life Sciences Completes Previously Announced Private Placement for Gross Proceeds of $8.3 Million
Pharmaceutical Investing U.S. FDA Approves PREVNAR 20, Pfizer's Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older
